Stem Cell Therapy in Myocardial Infarction: Still Therapeutic Hope?

1 Madonna, R. Stem cells and cardiac regeneration. Springer International: New York. 2016. MadonnaR Stem cells and cardiac regeneration Springer International New York 2016 10.1007/978-3-319-25427-2 Search in Google Scholar

2 Barzegar M, Kaur G, Gavins FNE, Wang Y, Boyer CJ, Alexander JS. Potential therapeutic roles of stem cells in ischemia-reperfusion injury. Stem Cell Res 2019; 37: 101421. BarzegarM KaurG GavinsFNE WangY BoyerCJ AlexanderJS Potential therapeutic roles of stem cells in ischemia-reperfusion injury Stem Cell Res 2019 37 101421 10.1016/j.scr.2019.10142130933723 Search in Google Scholar

3 Hao L, Zou Z, Tian H, Zhang Y, Zhou H, Liu L. Stem cell-based therapies for ischemic stroke. Biomed Res Int 2014; 2014: 2–15. HaoL ZouZ TianH ZhangY ZhouH LiuL Stem cell-based therapies for ischemic stroke Biomed Res Int 2014 2014 2 15 10.1155/2014/468748395565524719869 Search in Google Scholar

4 Sukhikh GT, Malaitsev VV, Bogdanova IM. Application potential of human fetal stem/progenitor cells in cell therapy. Bull Exp Biol Med 2008; 145(1): 114–121. SukhikhGT MalaitsevVV BogdanovaIM Application potential of human fetal stem/progenitor cells in cell therapy Bull Exp Biol Med 2008 145 1 114 121 10.1007/s10517-008-0031-819024018 Search in Google Scholar

5 Abbaspanah B, Momeni M, Ebrahimi M, Mousavi SH. Advances in perinatal stem cell research: a precious cell source for clinical applications. Regen Med 2018; 13(5): 595–610. AbbaspanahB MomeniM EbrahimiM MousaviSH Advances in perinatal stem cell research: a precious cell source for clinical applications Regen Med 2018 13 5 595 610 10.2217/rme-2018-001930129876 Search in Google Scholar

6 Kalra K, Tomar PC. Stem cell: basics, classification and applications. Am J Phytomed Clin Therapeut 2014; 2(7): 919–930. KalraK TomarPC Stem cell: basics, classification and applications Am J Phytomed Clin Therapeut 2014 2 7 919 930 Search in Google Scholar

7 Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013; 85(1): 3–10. KoliosG MoodleyY Introduction to stem cells and regenerative medicine Respiration. 2013 85 1 3 10 10.1159/00034561523257690 Search in Google Scholar

8 Li C, Chen S, Zhou Y, Zhao Y, Liu P, Cai J. Application of induced pluripotent stem cell transplants: Autologous or allogeneic? Life Sci 2018; 212: 145–149. LiC ChenS ZhouY ZhaoY LiuP CaiJ Application of induced pluripotent stem cell transplants: Autologous or allogeneic? Life Sci 2018 212 145 149 10.1016/j.lfs.2018.09.05730290185 Search in Google Scholar

9 Thanasegaran S, Cheng Z, Ito S, Nishio N, Isobe K. No immunogenicity of IPS cells in syngeneic host studied by in vivo injection and 3D scaffold experiments. Biomed Res Int 2013; 2013: 378207. ThanasegaranS ChengZ ItoS NishioN IsobeK No immunogenicity of IPS cells in syngeneic host studied by in vivo injection and 3D scaffold experiments Biomed Res Int 2013 2013 378207 10.1155/2013/378207365211723691499 Search in Google Scholar

10 Zhang Y, Mignone J, MacLellan WR. Cardiac regeneration and stem cells. Physiol Rev 2015; 95(4): 1189–1204. ZhangY MignoneJ MacLellanWR Cardiac regeneration and stem cells Physiol Rev 2015 95 4 1189 1204 10.1152/physrev.00021.2014460095326269526 Search in Google Scholar

11 Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95(9): 911–921. MessinaE De AngelisL FratiG MorroneS ChimentiS FiordalisoF Isolation and expansion of adult cardiac stem cells from human and murine heart Circ Res 2004 95 9 911 921 10.1161/01.RES.0000147315.71699.5115472116 Search in Google Scholar

12 Mollova M, Bersell K, Walsh S, Savla J, Das LT, Park SY, et al. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci USA 2013; 110(4): 1446–1451. MollovaM BersellK WalshS SavlaJ DasLT ParkSY Cardiomyocyte proliferation contributes to heart growth in young humans Proc Natl Acad Sci USA 2013 110 4 1446 1451 10.1073/pnas.1214608110355706023302686 Search in Google Scholar

13 Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324(5923): 98–102. BergmannO BhardwajRD BernardS ZdunekS Barnabé-HeiderF WalshS Evidence for cardiomyocyte renewal in humans Science 2009 324 5923 98 102 10.1126/science.1164680299114019342590 Search in Google Scholar

14 Kim SH, Cho JH, Lee YH, Lee JH, Kim SS, Kim MY, et al. Improvement in left ventricular function with intracoronary mesenchymal stem cell therapy in a patient with anterior wall ST-segment elevation myocardial infarction. Cardiovasc Drugs Ther 2018; 32(4): 329–338. KimSH ChoJH LeeYH LeeJH KimSS KimMY Improvement in left ventricular function with intracoronary mesenchymal stem cell therapy in a patient with anterior wall ST-segment elevation myocardial infarction Cardiovasc Drugs Ther 2018 32 4 329 338 10.1007/s10557-018-6804-z613316729956042 Search in Google Scholar

15 Zhang R, Yu J, Zhang N, Li W, Wang J, Cai G, et al. Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial. Stem Cell Res Ther 2021; 12(1): 33. ZhangR YuJ ZhangN LiW WangJ CaiG Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial Stem Cell Res Ther 2021 12 1 33 10.1186/s13287-020-02096-6779167433413636 Search in Google Scholar

16 Peregud-Pogorzelska M, Przybycień K, Baumert B, Kotowski M, Pius-Sadowska E, Safranow K, et al. The effect of intracoronary infusion of autologous bone marrow-derived lineage-negative stem/progenitor cells on remodeling of post-infarcted heart in patient with acute myocardial infarction. Int J Med Sci 2020; 17(8): 985–994. Peregud-PogorzelskaM PrzybycieńK BaumertB KotowskiM Pius-SadowskaE SafranowK The effect of intracoronary infusion of autologous bone marrow-derived lineage-negative stem/progenitor cells on remodeling of post-infarcted heart in patient with acute myocardial infarction Int J Med Sci 2020 17 8 985 994 10.7150/ijms.42561721115032410827 Search in Google Scholar

17 Nicolau JC, Furtado RHM, Silva SA, Rochitte CE, Rassi A, Moraes JBMC, et al.; MiHeart/AMI Investigators. Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial. Clin Cardiol 2018; 41(3): 392–399. NicolauJC FurtadoRHM SilvaSA RochitteCE RassiA MoraesJBMC MiHeart/AMI Investigators Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial Clin Cardiol 2018 41 3 392 399 10.1002/clc.22882648987029569254 Search in Google Scholar

18 Gastl M, Sürder D, Corti R, Faruque Osmany DMM, Gotschy A, von Spizcak J, et al. Effect of intracoronary bone marrow-derived mononuclear cell injection early and late after myocardial infarction on CMR-derived myocardial strain. Int J Cardiol 2020; 310: 108–115. GastlM SürderD CortiR Faruque OsmanyDMM GotschyA von SpizcakJ Effect of intracoronary bone marrow-derived mononuclear cell injection early and late after myocardial infarction on CMR-derived myocardial strain Int J Cardiol 2020 310 108 115 10.1016/j.ijcard.2020.01.02531982162 Search in Google Scholar

19 Fernández-Avilés F, Sanz-Ruiz R, Bogaert J, Casado Plasencia A, Gilaberte I, Belmans A, et al. Safety and efficacy of intracoronary infusion of allogeneic human cardiac stem cells in patients with ST-segment elevation myocardial infarction and left ventricular dysfunction. Circ Res 2018; 123(5): 579–589. Fernández-AvilésF Sanz-RuizR BogaertJ Casado PlasenciaA GilaberteI BelmansA Safety and efficacy of intracoronary infusion of allogeneic human cardiac stem cells in patients with ST-segment elevation myocardial infarction and left ventricular dysfunction Circ Res 2018 123 5 579 589 10.1161/CIRCRESAHA.118.31282329921651 Search in Google Scholar

20 Makkar RR, Kereiakes DJ, Aguirre F, Kowalchuk G, Chakravarty T, Malliaras K, et al. Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial. Eur Heart J 2020; 41(36): 3451–3458. MakkarRR KereiakesDJ AguirreF KowalchukG ChakravartyT MalliarasK Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial Eur Heart J 2020 41 36 3451 3458 10.1093/eurheartj/ehaa54132749459 Search in Google Scholar

21 Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE, Mukhametshina RT, Kwek XY, Cabrera-Fuentes HA, et al. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther 2018; 186: 73–87. OngSB Hernández-ReséndizS Crespo-AvilanGE MukhametshinaRT KwekXY Cabrera-FuentesHA Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities Pharmacol Ther 2018 186 73 87 10.1016/j.pharmthera.2018.01.001598100729330085 Search in Google Scholar

22 Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106(15): 1913–1918. StrauerBE BrehmM ZeusT KösteringM HernandezA SorgRV Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 2002 106 15 1913 1918 10.1161/01.CIR.0000034046.87607.1C12370212 Search in Google Scholar

23 Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study). Circ Res 2017; 121(11): 1279–1290. FloreaV RiegerAC DiFedeDL El-KhorazatyJ NatsumedaM BanerjeeMN Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study) Circ Res 2017 121 11 1279 1290 10.1161/CIRCRESAHA.117.311827874222328923793 Search in Google Scholar

24 Parizadeh SM, Jafarzadeh-Esfehani R, Ghandehari M, Parizadeh MR, Ferns GA, Avan A, et al. Stem cell therapy: A novel approach for myocardial infarction. J Cell Physiol 2019; 234(10): 16904–16912. ParizadehSM Jafarzadeh-EsfehaniR GhandehariM ParizadehMR FernsGA AvanA Stem cell therapy: A novel approach for myocardial infarction J Cell Physiol 2019 234 10 16904 16912 10.1002/jcp.2838130811054 Search in Google Scholar

25 Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364(9429): 141–148. WollertKC MeyerGP LotzJ Ringes-LichtenbergS LippoltP BreidenbachC Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Lancet 2004 364 9429 141 148 10.1016/S0140-6736(04)16626-915246726 Search in Google Scholar

26 Thakker R, Yang P. Mesenchymal stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med 2014; 16(7): 323–331. ThakkerR YangP Mesenchymal stem cell therapy for cardiac repair Curr Treat Options Cardiovasc Med 2014 16 7 323 331 10.1007/s11936-014-0323-4429592324898315 Search in Google Scholar

27 Marino L, Castaldi MA, Rosamilio R, Ragni E, Vitolo R, Fulgione C, et al. Mesenchymal stem cells from the Wharton's Jelly of the human umbilical cord: biological properties and therapeutic potential. Int J Stem Cells 2019; 12(2): 218–226. MarinoL CastaldiMA RosamilioR RagniE VitoloR FulgioneC Mesenchymal stem cells from the Wharton's Jelly of the human umbilical cord: biological properties and therapeutic potential Int J Stem Cells 2019 12 2 218 226 10.15283/ijsc18034665793631022994 Search in Google Scholar

28 Fukushima S, Sawa Y, Suzuki K. Choice of cell-delivery route for successful cell transplantation therapy for the heart. Future Cardiol 2013; 9(2): 215–227. FukushimaS SawaY SuzukiK Choice of cell-delivery route for successful cell transplantation therapy for the heart Future Cardiol 2013 9 2 215 227 10.2217/fca.12.8523463974 Search in Google Scholar

29 Ramkisoensing AA, Pijnappels DA, Askar SF, Passier R, Swildens J, Goumans MJ, et al. Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts. PLoS One 2011; 6(9): e24164. RamkisoensingAA PijnappelsDA AskarSF PassierR SwildensJ GoumansMJ Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts PLoS One 2011 6 9 e24164 10.1371/journal.pone.0024164317033321931658 Search in Google Scholar

30 Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Clarke MJ, et al. Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. PLoS One 2012; 7(5): e37373. CliffordDM FisherSA BrunskillSJ DoreeC MathurA ClarkeMJ Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes PLoS One 2012 7 5 e37373 10.1371/journal.pone.0037373336002722655042 Search in Google Scholar

31 Tseliou E, Pollan S, Malliaras K, Terrovitis J, Sun B, Galang G, et al. Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains. J Am Coll Cardiol 2013; 61(10): 1108–1119. TseliouE PollanS MalliarasK TerrovitisJ SunB GalangG Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains J Am Coll Cardiol 2013 61 10 1108 1119 10.1016/j.jacc.2012.10.05223352785 Search in Google Scholar

32 Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 2012; 59(10): 942–953. LiTS ChengK MalliarasK SmithRR ZhangY SunB Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells J Am Coll Cardiol 2012 59 10 942 953 10.1016/j.jacc.2011.11.029329277822381431 Search in Google Scholar